10 AstraZeneca executives

These ten AstraZeneca executives have held CFO, executive vice president, senior vice president and country president roles at AstraZeneca, covering BioPharmaceuticals, the International region, the US, the UK, India, the Nordics and the Middle East and Africa. Readers can learn how AstraZeneca leaders run finance, business units, country organizations and regional commercial operations.

10 professionals2 companiesData retrieved October 8, 2026

Professionals to explore

  1. Aradhana Sarin

    LinkedIn

    Experience: Executive Director and Chief Financial Officer · AstraZeneca

    Executive Director and Chief Financial Officer at AstraZeneca since August 2021, listed at the C-Level in Finance & Accounting, and also listed as CFO at AstraZeneca since January 2021. Former CFO at Alexion Pharmaceuticals (2019–2021), before the two current AstraZeneca finance roles listed on the profile.

    Is this you? Claim your profile and get paid for calls.

  2. Bhavana Agrawal

    LinkedIn

    Experience: Chief Financial Officer - Middle East & Africa · AstraZeneca

    Chief Financial Officer - Middle East & Africa at AstraZeneca since September 2026, listed at the C-Level. Former Executive Director (2024–2026) and Chief Financial Officer - India (2023–2026) at AstraZeneca India, Chief Financial Officer Designate - India (2023), and former CFO services - Emerging Markets at GE HealthCare (2021–2022).

    Is this you? Claim your profile and get paid for calls.

  3. Iskra Reic

    LinkedIn

    Experience: EVP, International · AstraZeneca

    EVP, International at AstraZeneca since December 2024, a region the profile says includes China, Asian and Eurasian markets, Middle East & Africa, Latin America, Australia and New Zealand. Also listed as EVP, Vaccines & Immune Therapies since 2021, and former EVP, Europe & Canada (2019–2022), EVP, Europe (2017–2019) and Area VP, Russia & Eurasia (2016–2017).

    Is this you? Claim your profile and get paid for calls.

  4. Lars-Johan Cederbrant

    LinkedIn

    Experience: Chief Financial Officer Nordics & Sweden, Board member · AstraZeneca

    Chief Financial Officer Nordics & Sweden, Board member at AstraZeneca since November 2025. Former Chief Financial Officer AstraZeneca AB Sweden (2022–2025), VP Finance R&D Oncology (2020–2022), Head of Finance CFO, Europe (& International) Oncology (2017–2019) and Global Finance Director CFO, Respiratory Therapy Area (2016–2017) at AstraZeneca.

    Is this you? Claim your profile and get paid for calls.

  5. Mani Sharma

    LinkedIn

    Experience: Senior Vice President, Group Controller and Head of Global Finance Services · AstraZeneca

    Senior Vice President, Group Controller and Head of Global Finance Services at AstraZeneca since November 2022. Former Senior Vice President, Group Controller and Head of Deal Finance (2020–2022) and Senior Vice President, CFO Global Oncology Business Unit and Head of Deal Finance (2018–2020) at AstraZeneca, and Non Executive Director at an NHS Trust since 2025.

    Is this you? Claim your profile and get paid for calls.

  6. Praveen Rao Akkinepally

    LinkedIn

    Experience: Country President & Managing Director · AstraZeneca India

    Country President & Managing Director at AstraZeneca India since July 2025. Former Head of Oncology Business Unit, AstraZeneca India (2023–2025), and former Global Head of Lung Cancer Commercialization, Global Marketing (2021–2023), US Head of Marketing, Immuno-Oncology Lung (2019–2021) and US Head of Marketing, Tagrisso & Iressa (2017–2019) at AstraZeneca.

    Is this you? Claim your profile and get paid for calls.

  7. Rick R. Suárez

    LinkedIn

    Experience: US President and SVP US BioPharmaceuticals Business Unit · AstraZeneca

    US President and SVP US BioPharmaceuticals Business Unit at AstraZeneca since January 2026. Former Country President Spain (2020–2026), Senior Vice President, US Market Access (BioPharma Oncology) and PAP (2018–2020), Vice President, US Market Access (2017–2018) and Executive Director, Managed Markets, National Health Plans (2014–2017) at AstraZeneca.

    Is this you? Claim your profile and get paid for calls.

  8. Ruud Dobber

    LinkedIn

    Experience: Executive Vice President and President, BioPharmaceuticals Business Unit · AstraZeneca

    Executive Vice President and President, BioPharmaceuticals Business Unit at AstraZeneca since 2019, responsible per the profile for product strategy and commercial delivery across Cardiovascular, Renal & Metabolism, Respiratory and Immunology, and Vaccines & Immune Therapies. Also listed as President, AstraZeneca US and Executive Vice President, North America since 2016, and former Executive Vice President Europe (2013–2016).

    Is this you? Claim your profile and get paid for calls.

  9. Tom Keith-Roach

    LinkedIn

    Experience: President, Astrazeneca UK · AstraZeneca

    President, AstraZeneca UK since March 2020; the profile describes an overhauled strategy that grew the UK business from 14th in rank. Former Global SVP, Respiratory & Immunology (2015–2020), Global VP, Brilinta (2013–2015), Area VP, Eastern Europe (2010–2013) and President, AstraZeneca Korea (2008–2010).

    Is this you? Claim your profile and get paid for calls.

  10. Umut Ozkul

    LinkedIn

    Experience: CFO · AstraZeneca

    CFO at AstraZeneca since August 2019, based in Istanbul, with a profile citing more than 20 years in finance and a seat on the management board. Former CFO at Schindler Türkeli Asansör (2018–2019), and former External Affairs Director (2016–2018), CFO - GCC (2015–2016) and CFO - Turkey (2009–2016) at Johnson & Johnson Innovative Medicine.

    Is this you? Claim your profile and get paid for calls.

Choose the right perspective

Match the executive's business unit or country to your question, since a BioPharmaceuticals or International region leader sees different medicines, payers and regulators than a country president or a regional CFO. Check each role's dates to confirm whether the experience you need is current or from an earlier period.

Questions to take into the conversation

  1. 01How does AstraZeneca decide which therapy areas, launches and markets get more investment?
  2. 02What do AstraZeneca country and business unit leaders look for when choosing a new commercial, market access or service partner?
  3. 03How does a global pharmaceutical company balance central portfolio strategy with country-level pricing and access decisions?

About this directory

This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.

Other perspectives in Pharmaceuticals